仅供临床科研使用
icobrain ms 了解更多
销售价格： ￥ N/A
商品编号： AI-0132-0381
软件语言： 英文
器械分类： II
生产厂家： icometrix
公司网址： https://icometrix.com/
认证信息： FDA
系统要求： Windows
交付方式： 下载安装
  • 软件概览
  • 推荐配置
  • 典型病例
  • 软件教程
  • 临床文献
  • 用户评价
  • 产品彩页

软件概览

Multiple Sclerosis

Accurately visualize lesion and brain volume changes over time in multiple sclerosis


icobrain ms

icobrain ms is designed to support the detection and tracking of disease progression, and the evaluation of treatment effectiveness. 

It provides a quantitative analysis of the inflammatory component of the disease, assessing longitudinal changes in FLAIR and T1 lesions. Additionally, icobrain ms can be used to assess changes in brain volume over time, which can be compared to age- and sex-matched healthy individuals. 

1754229517474.png


The icometrix multiple sclerosis care management platform

1754229449171.png

Click to watch the video


icobrain ms+

icobrain ms+ (only available for research) can be used to evaluate the central vein sign and paramagnetic rim lesions based on susceptibility-weighted imaging, and additional brain volumes, and cross-sectional surface area of the C2-C3 section of the cervical spinal cord from T1-w images.

1754229530551.png

1754229537353.png


Key scientific publications

A deep learning model for brain segmentation across pediatric and adult populations

Simarro et al. (2024)

Start Now

Brain volume loss in Japanese patients with multiple sclerosis is present in the early to middle stage of the disease

Fujimori & Nakashima (2024)

Start Now

Patient-reported outcome measurements in a selective cohort of relapsing–remitting multiple sclerosis patients: relationships with physical disability, cognitive impairment, and MRI-derived metrics

London et al. (2023)

Start Now

Brain volume loss in multiple sclerosis is independent of disease activity and might be prevented by early disease-modifying therapy

Slezáková et al. (2023)

Start Now

Associations between neurofilament light chain levels, disease activity and brain atrophy in progressive multiple sclerosis

Szilasiova et al. (2022)

Start Now

Cost-Effectiveness Analysis of AI-Assisted Radiological Assessment in Patients With Relapsing Remitting Multiple Sclerosis in the UK

Esposito et al. (2022)

Start Now

icobrain ms 5.1: Combining Unsupervised and Supervised Approaches for Improving the Detection of Multiple Sclerosis Lesions.

Rakic et al. (2021)

Start Now

Patterns of cortical grey matter thickness reduction in multiple sclerosis

Fujimori et al. (2021)

Start Now

Health Economic Impact of Software-Assisted Brain MRI on Therapeutic Decision-Making and Outcomes of Relapsing-Remitting Multiple Sclerosis Patients—A Microsimulation Study

Sima et al. (2021)

Start Now

A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis

Van Hecke et al. (2021)

Start Now

Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study

Horakova et al. (2020)

Start Now

Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis

Akaishi et al. (2020)


推荐配置


典型病例


软件教程


临床文献


用户评价

What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.

Tiron Pechet, Radiologist at Shields Healthcare Group

With icobrain, we can provide a technologic level of observation that previously has only been available for centers in clinical trials. Now, every patient can be measured this way, can be assessed, and we are using this data to make important changes in our day-to-day patient management.

With icobrain, we can provide a technologic level of observation that previously has only been available for centers in clinical trials. Now, every patient can be measured this way, can be assessed, and we are using this data to make im


产品彩页


请完善个人信息

非常抱歉，您只有购买软件后才能查看完整软件教程！

看了此商品的会员还在看
测试版
版本号 软件大小 下载地址
01 1m 下载
正式版
版本号 软件大小 下载地址
01 1m 下载